Parkódín Filmuhúðuð tafla 500 mg/10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

parkódín filmuhúðuð tafla 500 mg/10 mg

teva b.v.* - paracetamolum inn; codeini phosphas hemihydricus - filmuhúðuð tafla - 500 mg/10 mg

Parkódín forte Filmuhúðuð tafla 500 mg/30 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

parkódín forte filmuhúðuð tafla 500 mg/30 mg

teva b.v.* - paracetamolum inn; codeini phosphas hemihydricus - filmuhúðuð tafla - 500 mg/30 mg

Travoprost/Timolol Medical Valley Augndropar, lausn 40 míkróg/ml + 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

travoprost/timolol medical valley augndropar, lausn 40 míkróg/ml + 5 mg/ml

medical valley invest ab - travoprostinum inn; timololum maleat - augndropar, lausn - 40 míkróg/ml + 5 mg/ml

Dimethyl fumarate Neuraxpharm Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Travoprost/Timolol STADA Augndropar, lausn 40 míkróg/ml + 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

travoprost/timolol stada augndropar, lausn 40 míkróg/ml + 5 mg/ml

stada arzneimittel ag - travoprostinum inn; timololum maleat - augndropar, lausn - 40 míkróg/ml + 5 mg/ml

Odomzo Evrópusambandið - íslenska - EMA (European Medicines Agency)

odomzo

sun pharmaceutical industries europe b.v. - sonidegib tvífosfat - krabbamein, basalfrumur - Æxlishemjandi lyf - odomzo er ætlað til meðferðar hjá fullorðnum sjúklingum með staðbundið langt gengið grunnfrumukrabbamein (bcc) sem ekki er hægt að lækna með skurðaðgerð eða geislameðferð.

Idefirix Evrópusambandið - íslenska - EMA (European Medicines Agency)

idefirix

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - Ónæmisbælandi lyf - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Vyvgart Evrópusambandið - íslenska - EMA (European Medicines Agency)

vyvgart

argenx - efgartigimod alfa - myasthenia gravis - Ónæmisbælandi lyf - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.